Decision spine
Frames the controlling thesis, evidence status, buyer implications, and research-use limits.
Immunology
Zemi Dossier
Research-use only
Immune Aging Supply Chain
A decision package on immune aging as a constrained supply-chain system linking thymic output, clonal hematopoiesis, inflammation, and resilience.
Decision this dossier helps answer
Which immune-aging interventions target the binding node, and when would restoration create more risk than resilience?
Problem this dossier solves
Immune aging is bottlenecked, not merely depleted.
The dossier treats immune resilience as a supply chain with constrained inputs, distorted clones, inflammatory routing, and recovery limits. It helps buyers identify whether to restore, suppress, monitor, or avoid intervention by node.
What is moving: current field evidence and platform activity
What is unresolved: decision-grade proof, endpoint logic, and failure modes
What Zemi solves: evidence-gated next-study strategy
Full decision package
111-page research report plus 45-sheet Evidence & Decision Workbook
Buy now
$3,500$5,500Launch price
Controlling thesis
Immune aging is bottlenecked, not merely depleted.
The dossier treats immune resilience as a supply chain with constrained inputs, distorted clones, inflammatory routing, and recovery limits. It helps buyers identify whether to restore, suppress, monitor, or avoid intervention by node.
A Zemi Dossier turns uncertain emerging research into a decision package: what is known, what is inferred, what is hypothetical, what would falsify the thesis, and what should be built, funded, avoided, monitored, or validated next.
Research report preview
First 30 pages of the actual Immune Aging Supply Chain research report.
The public page shows the real document style, density, evidence posture, and decision framing before a buyer requests access to the full Zemi Dossier package.
Research report
The research report is the argument. It is not the whole product.
The PDF research report is the structured argument: field status, evidence maturity, buyer implications, falsifiable hypotheses, power-calculated next studies, strategic recommendations, limitations, and traceability posture.
Inspectable infrastructure
Pairs the report with claim ledgers, evidence tables, power rows, audit surfaces, and decision tools.
Executable next studies
Links hypotheses to endpoint logic, assumptions, sample-size logic, budget, and timeline planning.
Research report table of contents
Public TOC generated from the source report.
The full research report is delivered as a licensed PDF. This table shows the decision structure without publishing the full product.
| Section | What it covers | Buyer value |
|---|---|---|
| Decision Brief Read This First | Turns the report into immediate buyer triage: what matters now, what is still uncertain, and what to do next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Contents | Shows the report structure and where to inspect the argument, evidence, workbook logic, and limits. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Executive Summary | Condenses the dossier thesis, evidence posture, buyer implications, and next-study priorities. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Scope and Evidence Integrity | Defines the evidence window, source boundaries, research-use limits, and labeling discipline. | Lets the buyer audit support strength before relying on the package. |
| Decision Snapshot Overview | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Buy Build Wait Avoid | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Buyer Decision Matrix | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Source Quality Dashboard | Shows how strong the source base is and where conclusions depend on indirect or thinner support. | Lets the buyer audit support strength before relying on the package. |
| The Immune Supply Chain Ledger | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Rate Limiting Node Classifier Rln | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| The Rln Archetype Walkthrough | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Current Signal Refresh 2025 2026 | Frames the field's June 2026 state, active programs, research fronts, and timing signals. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Cross Axis Convergence Map | Shows how separate research signals converge, diverge, or interact across domains, mechanisms, or study layers. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Cross Domain Synthesis Claims | Shows how separate research signals converge, diverge, or interact across domains, mechanisms, or study layers. | Lets the buyer audit support strength before relying on the package. |
| Evidence Maturity Matrix | Links claims to source support so users can separate what is known, inferred, and hypothetical. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Comparative Platform Mechanism Matrix | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Key Findings | Summarizes the most decision-relevant findings and their implications for the dossier thesis. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Supply-chain thesis | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Binding node | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Gene-resolved marrow | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Functional-output bridge | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The figure-eight | Supports inspection of the report's visual evidence, calculations, or supplemental decision material. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Compensation is pathogenic | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Restoration routes | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Thymic restoration -> function | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Reserve not state | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Immune resilience | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Warehouse + CMV pivot | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Metformin gene-specificity | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Rescue equals risk | States boundaries, uncertainties, and evidence that would weaken or change the dossier thesis. | Shows where the thesis could fail or require more validation before action. |
| Immune-age oncology bridge | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Program landscape | Frames the field's June 2026 state, active programs, research fronts, and timing signals. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Peripheral niche node | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Quarantine: TRIIM-X | States boundaries, uncertainties, and evidence that would weaken or change the dossier thesis. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Evidentiary floor | Shows how strong the source base is and where conclusions depend on indirect or thinner support. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Quantitative Evidence | Links claims to source support so users can separate what is known, inferred, and hypothetical. | Lets the buyer audit support strength before relying on the package. |
Evidence & Decision Workbook
The workbook is the decision engine.
A locked public preview of selected workbook-derived sheets: sheet structure, decision modules, power rows, traceability, and audit posture. Licensed buyers receive the full workbook files.
Read-only workbook preview with clipped values and no formulas. Licensed buyers receive the full Evidence & Decision Workbook with editable assumptions and working files.
Workbook inventory
Delivered workbook sheets.
Full inventories belong on dossier pages, not the homepage. Sheet names below are extracted from the actual workbook file.
| # | Workbook sheet | What it does |
|---|---|---|
| 1 | 1. Workbook Guide | Navigation layer for using the workbook, understanding sheet roles, and following the decision package. Public preview exposes Hypotheses, 14: 5 Flagship + 5 Frontier + 4. fields and clipped entries such as Executable modules, The RLN Classifier., Bright. |
| 2 | 2. Claim Ledger | Claim-by-claim ledger showing verdicts, source support, inference status, and decision relevance. Public preview exposes #, Finding, Label, Claim (as used) fields and clipped entries such as S1, Finding 1 — In people with HIV, CMV., In people with HIV, CMV. |
| 3 | 3. Evidence Table | Evidence-verification surface for checking sources, support quality, and the audit trail. Public preview exposes Identifier, Title, Journal/Source, Year fields and clipped entries such as DOI:10.1002/advs.202521776, Engineering Immune Cell to., Advanced. |
| 4 | 4. Source-Support Verdicts | Independent check on whether key claims are actually supported by cited sources. Public preview exposes S4, Finding 4 — In CHIP,., SUPPORTS_EXACTLY, PMID:42268520 fields and clipped entries such as S5, Finding 5 — MAPKAP kinase 2 (MK2)., SUPPORTS_EXACTLY. |
| 5 | 5. Source Quality Summary | Summary of source strength, gaps, and areas where conclusions depend on weaker evidence. Public preview exposes Claims audited, 271 fields and clipped entries such as Source-kept (source pack), Excluded. |
| 6 | 6. Evidence Maturity Matrix | Evidence-verification surface for checking sources, support quality, and the audit trail. Public preview exposes Node, Human assoc., Mechanism, Functional data fields and clipped entries such as Thymic output, Low, High (mouse). |
| 7 | 7. Thymic-Output Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S2, Finding 2 — In TCR reporter mouse., In TCR reporter mouse models and.. |
| 8 | 8. HSC-Clonal CHIP Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S4, Finding 4 — In CHIP, gene-specific., In CHIP, gene-specific mechanisms in.. |
| 9 | 9. Repertoire-CMV Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S1, Finding 1 — In people with HIV, CMV., In people with HIV, CMV is a nearly.. |
| 10 | 10. Inflammaging Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S8, Finding 8 — Immunosenescence and., Immunosenescence and immunotherapy.. |
| 11 | 11. Effector-Resilience Tracker | Segments the field by relevant biology so buyer decisions are not overgeneralized. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S28, Finding 28 — Long-acting rhIL-7-hyFc., Long-acting rhIL-7-hyFc induced.. |
| 12 | 12. Measurability-Reserve Track | Segments the field by relevant biology so buyer decisions are not overgeneralized. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S51, Finding 51 — At age 40, individuals., At age 40, individuals with poor.. |
| 13 | 13. Trial - Catalyst Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes NCT, Title, Status, Phase fields and clipped entries such as NCT02348801, Lifestyle Intervention Strategy to., COMPLETED. |
| 14 | 14. Company - Sponsor Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Company, Asset, Modality, Node fields and clipped entries such as TECregen AG, thymopoietic biologics, thymic epithelial regeneration. |
| 15 | 15. Safety - Risk Tracker | Captures failure modes and constraints that could invalidate or narrow a program. Public preview exposes CMV antiviral control, Low, Low, Low fields and clipped entries such as Senolytic, Moderate, Low. |
| 16 | 16. Biomarker - Endpoint Tracke | Tracks biomarkers or readouts that determine whether the thesis is moving toward testable evidence. Public preview exposes TCF7 immune-resilience, Restorable construct, survival-linked, candidate functional endpoint. fields and clipped entries such as. |
| 17 | 17. Regulatory Tracker | Tracks regulatory, endpoint, reimbursement, or qualification requirements that shape testing strategy. Public preview exposes Question, Status / channel, Note fields and clipped entries such as Is immune age a qualifiable endpoint?, NOT today,. |
| 18 | 18. Hypotheses Ledger | Maps hypotheses to evidence state, falsification logic, endpoints, and next-study design. Public preview exposes Hypothesis, Tier, Paradigm, Primary (functional) endpoint fields and clipped entries such as F1 - Rate-limiting-node-matched., Flagship,. |
| 19 | 19. Most-Valuable Next Studies | Prioritizes next studies that could change the decision, including endpoints and evidence gates. Public preview exposes rank, study_id, linked_power_row, population fields and clipped entries such as MVNS-1-RLN-validation, F1, Adults >=60 profiled by RLN. |
| 20 | 20. Validation - Falsification | Connects proposed validation work to falsification criteria, readouts, and decision gates. Public preview exposes Node-match > age (functional), F1, supply-chain thesis + RLN, peripheral-only lever wins where. fields and clipped entries such as TET2. |
| 21 | 21. Figure Source Map | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes #, Figure ID, Data type, Status fields and clipped entries such as fig02_node_distribution, verified-quantitative, PASS. |
| 22 | 22. Figure Attempt Ledger | Figure and numeric reproduction log for validating calculations, chart inputs, or displayed values. Public preview exposes Figure ID, Backend, Status, Limitation note fields and clipped entries such as fig01_grade_recalibration, deterministic, PASS. |
| 23 | 23. Verification - Search Log | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes #, Source/DB, Query, Hits fields and clipped entries such as pubmed, thymic involution regeneration, pubmed. |
| 24 | 24. Excluded Claims | Disposition log for rejected, bounded, or quarantined claims so they do not leak into the decision thesis. Public preview exposes Excluded 27 — In a multicenter., off-topic, PMID:41521447, Excluded confirmed (below. fields and clipped entries such as. |
| 25 | 25. Salvage + Quarantine | Disposition log for rejected, bounded, or quarantined claims so they do not leak into the decision thesis. Public preview exposes SALVAGE, Excluded 1 — CIRM-funded research., CIRM-funded research proposes., Verified program fact (grounded. fields and clipped. |
| 26 | 26. Traceability Certificate | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes #, Finding, Node (section), Primary source fields and clipped entries such as S1, peripheral-repertoire-CMV, PMID:41860720. |
| 27 | 27. Score Basis | Explains how scores or ratings were assigned so the decision instrument can be inspected. Public preview exposes fig04 gene-resolved CHIP, inflammatory/atherogenic 0-4, cited mechanism literature per. fields and clipped entries such as fig10 maturity matrix,. |
| 28 | 28. Power Calculations | Power-calculation layer for assumptions, endpoint logic, computed sample sizes, and sensitivity checks. Public preview exposes hypothesis_id, study_id, endpoint, test_type fields and clipped entries such as F1, MVNS-1-RLN-validation, Node-matched vs age -. |
| 29 | 29. Competitive Landscape | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Company, Asset/platform, Modality, Node fields and clipped entries such as TECregen AG, thymopoietic biologics, thymic epithelial regeneration. |
| 30 | 30. Negative Currentness Scan | Captures failure modes and constraints that could invalidate or narrow a program. Public preview exposes scan_date_utc, topic, query_or_registry_check, newest_signal_seen fields and clipped entries such as 2026-06-16, TECregen financing / clinical status,. |
| 31 | 31. Buyer Trigger Matrix | Monitoring surface for emerging signals, update triggers, and evidence changes that could alter the decision. Public preview exposes Gene-resolved clonal loop-break., INVEST / GO where genotype-matched, TET2-stratified functional., Recruiting/early CV. |
| 32 | RLN_Input_Template | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Repertoire & CMV, TCR diversity, CMV serostatus +., ____ fields and clipped entries such as Peripheral niche, Lymph-node stromal integrity. |
| 33 | RLN_Feature_Score | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes PERIPHERAL-NICHE-LIMITED, Peripheral-niche deficit:., 0, 1 fields and clipped entries such as INFLAMMAGING-TONE-LIMITED, Inflammaging deficit:. |
| 34 | RLN_Class_Output | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Archetype (deficit scores), Dominant node, Confidence, OUTPUT CLASS / branch. fields and clipped entries such as Thymic-output-limited (open).,. |
| 35 | RLN_Decision_Rules | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Class (binding node), Recommended strategy, Primary functional endpoint, Required safety readout fields and clipped entries such as. |
| 36 | RLN_Gene_Rules | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Driver gene (marrow node), Gene-matched strategy, Contraindication, Safety flag fields and clipped entries such as TET2, IL-1B/NLRP3 blockade.,. |
| 37 | RLN_Validation_Sweep | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes case_id, deficit_vector, window_status, driver_gene fields and clipped entries such as marrow-driver-TET2, 1,3,1,0,1,1, open. |
| 38 | RLN_Minimum_Assay_Panel | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes CMV serostatus + memory-inflation., CMV, Required fields and clipped entries such as Lymph-node stromal surrogate, Niche, Research-only. |
| 39 | RLN_Archetype_Cards | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Archetype, Profile (deficits), Binding node, Matched move fields and clipped entries such as Thymic-output-limited (open window), thymic 3, rest. |
| 40 | RLN_Validation_Log | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Linked flagship, F1 (node-matched beats age/clock. fields and clipped entries such as Validation cohort, RLN-classified adults >=60;., Held-out AUC. |
| 41 | RLN_Traceability_Map | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes RLN element, Maps to claim/finding, Evidence ID, Figure fields and clipped entries such as Thymic-output axis, kf-supply-chain; thymic. |
| 42 | Formula Cache Map | Power-calculation layer for assumptions, endpoint logic, computed sample sizes, and sensitivity checks. Public preview exposes source_sheet, live_cell, scope_or_id, output_name fields and clipped entries such as 28. Power Calculations, J2, F1. |
| 43 | Package Reconciliation Map | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes surface, field_name_or_key, expected_value, source_of_truth fields and clipped entries such as manifest, audited, _build/manifest.json. |
| 44 | 38. Version Registry | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes v1.0, June 2026, Initial premium Tier C build from., Claude (Opus 4.8) fields and clipped entries such as Model, Immune Supply-Chain. |
| 45 | 39. Audit Issues Log | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes #, Issue, Status, Resolution fields and clipped entries such as AI-1, Workbook genuinely executable?, RESOLVED. |
Power-calculated next studies
Power calculations are the execution bridge.
Power calculations are planning-grade research calculations for endpoint logic, assumptions, sample size, budget, and timeline. They do not prove hypotheses or constitute clinical protocol.
| Hypothesis | Primary endpoint | Test | Effect | α | Power | Computed n | Design n |
|---|---|---|---|---|---|---|---|
| F1 | Node-matched vs age - functional response | Two-proportion | 0.65 | 0.05 | 0.80 | 96 | 96 |
| F2 | Gene-matched loop-break - TET2 stratum | Two-proportion | 0.55 | 0.05 | 0.80 | 96 | 96 |
| F3 | Central-output restoration -> SASP burden | Two-sample means (Cohen's d) | 0.6 | 0.05 | 0.80 | 44 | 44 |
| F4 | Two-factory combination (interaction) | Two-proportion | 0.7 | 0.05 | 0.80 | 93 | 93 |
| F5 | Reserve index - response-prediction AUC | AUC (Hanley-McNeil, external) | 0.78 | 0.05 | 0.80 | 240 | 240 |
Release audit discipline
Audit posture is part of the product.
Public pages do not publish exact audit scores. They should state the release discipline, revision posture, and limitations without implying peer review or validated clinical guidance.
Research-use decision package
Not medical advice, clinical guidance, investment advice, or a clinical protocol.
Known / inferred / hypothetical
The package separates cited evidence from inference and frontier hypothesis generation.
Audit-gated and revision-controlled
Adversarial audit checks source support, formulas, figures, limitations, and release readiness.
Buy this dossier
Full decision package — 111-page report + 45-sheet workbook
Buy now
- Decision research report (111 pages, PDF)
- Evidence & Decision Workbook (45 sheets, .xlsx) — claims, source-support verdicts, power calculations, traceability, and audit log
- Live, editable power-calculated next studies
$3,500$5,500Launch price